Myocardial bioenergetic abnormalities in a canine model of left ventricular dysfunction

Department of Medicine, University of Minnesota, Minneapolis.

OBJECTIVES. The purpose of this study was to assess high energy phosphate compound metabolism in remodeled left ventricular myocardium. BACKGROUND. The development of heart failure several years after myocardial infarction is often unexplained. Certain abnormalities of remodeled myocardium suggest that structural changes occurring in viable myocardium after discrete myocardial damage may contribute to the later appearance of heart failure. Whether these abnormalities alter metabolism in the surviving muscle and thereby possibly contribute to ventricular dysfunction is unknown. METHODS. High energy phosphate compound metabolism was assessed using spatially localized phosphorus-31 nuclear magnetic resonance spectroscopy. Eleven dogs with documented left ventricular dysfunction, resulting from infarction produced by transmyocardial direct current shock, were compared with eight normal dogs. Analyses were performed at baseline and during coronary hyperperfusion induced by intravenous adenosine. Myocardial blood flow was measured with radioactive microspheres. RESULTS. The creatine phosphate/adenosine triphosphate (CP/ATP) ratio was significantly reduced in the left ventricular dysfunction group in both the subepicardium ([mean +/- SE] 1.94 +/- 0.08 vs. 2.32 +/- 0.13, p = 0.019) and the subendocardium (1.71 +/- 0.07 vs. 2.05 +/- 0.07, p = 0.004). Intravenous adenosine produced significant coronary hyperemia in both groups but was less marked in dogs with left ventricular dysfunction. The improvement in myocardial perfusion was accompanied by a significant increase in the subendocardial CP/ATP ratio (from 1.71 +/- 0.07 to 1.92 +/- 0.08, p = 0.01) in dogs with left ventricular dysfunction. CONCLUSIONS. An abnormal transmural distribution of high energy phosphate compounds is evident in remodeled myocardium. This abnormality may be related in part to mismatch of oxygen delivery and demand.

This article has been cited by other articles:

				W. C. Stanley, F. A. Recchia, and G. D. Lopaschuk Myocardial Substrate Metabolism in the Normal and Failing Heart Physiol Rev, July 1, 2005; 85(3): 1093 - 1129. [Abstract] [Full Text] [PDF]

				A. V. Naumova, R. G. Weiss, and V. P. Chacko Regulation of murine myocardial energy metabolism during adrenergic stress studied by in vivo 31P NMR spectroscopy Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1976 - H1979. [Abstract] [Full Text] [PDF]

				J. Zhang, N. Wilke, Y. Wang, Y. Zhang, C. Wang, M. H.J. Eijgelshoven, Y. K. Cho, Y. Murakami, K. Ugurbil, R. J. Bache, et al. Functional and Bioenergetic Consequences of Postinfarction Left Ventricular Remodeling in a New Porcine Model: MRI and 31P-MRS Study Circulation, September 1, 1996; 94(5): 1089 - 1100. [Abstract] [Full Text]

				J. Zhang and K. M. McDonald Bioenergetic Consequences of Left Ventricular Remodeling Circulation, August 15, 1995; 92(4): 1011 - 1019. [Abstract] [Full Text]

				T. Yabe, K. Mitsunami, T. Inubushi, and M. Kinoshita Quantitative Measurements of Cardiac Phosphorus Metabolites in Coronary Artery Disease by 31P Magnetic Resonance Spectroscopy Circulation, July 1, 1995; 92(1): 15 - 23. [Abstract] [Full Text]

				J. N. Cohn Structural Basis for Heart Failure : Ventricular Remodeling and Its Pharmacological Inhibition Circulation, May 15, 1995; 91(10): 2504 - 2507. [Full Text]

				K. M. McDonald, J. Mock, A. D'Aloia, T. Parrish, K. Hauer, G. Francis, A. Stillman, and J. N. Cohn Bradykinin Antagonism Inhibits the Antigrowth Effect of Converting Enzyme Inhibition in the Dog Myocardium After Discrete Transmural Myocardial Necrosis Circulation, April 1, 1995; 91(7): 2043 - 2048. [Abstract] [Full Text]